krejci p - Search Results

Year	Number of Results
1973	2
1975	1
1976	2
1980	4
1981	6
1982	1
1983	2
1984	1
1986	2
1987	1
1989	2
1992	2
1994	2
1995	1
1996	1
1999	2
2001	4
2002	1
2003	1
2004	3
2005	1
2006	2
2007	5
2008	4
2009	5
2010	6
2011	5
2012	6
2013	5
2014	7
2015	10
2016	6
2017	9
2018	9
2019	4
2020	7
2021	6
2022	9

1

A registry of achondroplasia: a 6-year experience from the Czechia and Slovak Republic.

Pesl M, Verescakova H, Skutkova L, Strenkova J, Krejci P. Pesl M, et al. Among authors: krejci p. Orphanet J Rare Dis. 2022 Jun 16;17(1):229. doi: 10.1186/s13023-022-02374-x. Orphanet J Rare Dis. 2022. PMID: 35710503 Free PMC article.

2

The loss of polyphenol oxidase function is associated with hilum pigmentation and has been selected during pea domestication.

Balarynová J, Klčová B, Sekaninová J, Kobrlová L, Cechová MZ, Krejčí P, Leonova T, Gorbach D, Ihling C, Smržová L, Trněný O, Frolov A, Bednář P, Smýkal P. Balarynová J, et al. Among authors: krejci p. New Phytol. 2022 Sep;235(5):1807-1821. doi: 10.1111/nph.18256. Epub 2022 Jun 10. New Phytol. 2022. PMID: 35585778

3

Intervertebral disc degeneration is rescued by TGFβ/BMP signaling modulation in an ex vivo filamin B mouse model.

Zieba J, Forlenza KN, Heard K, Martin JH, Bosakova M, Cohn DH, Robertson SP, Krejci P, Krakow D. Zieba J, et al. Among authors: krejci p. Bone Res. 2022 Apr 26;10(1):37. doi: 10.1038/s41413-022-00200-5. Bone Res. 2022. PMID: 35474298 Free PMC article.

4

LuminoCell: a versatile and affordable platform for real-time monitoring of luciferase-based reporters.

Weissová K, Fafílek B, Radaszkiewicz T, Celiker C, Macháčková P, Čechová T, Šebestíková J, Hampl A, Bryja V, Krejčí P, Bárta T. Weissová K, et al. Among authors: krejci p. Life Sci Alliance. 2022 Apr 19;5(8):e202201421. doi: 10.26508/lsa.202201421. Print 2022 Aug. Life Sci Alliance. 2022. PMID: 35440493 Free PMC article.

5

Lyn Phosphorylates and Controls ROR1 Surface Dynamics During Chemotaxis of CLL Cells.

Dave Z, Vondálová Blanářová O, Čada Š, Janovská P, Zezula N, Běhal M, Hanáková K, Ganji SR, Krejci P, Gömöryová K, Peschelová H, Šmída M, Zdráhal Z, Pavlová Š, Kotašková J, Pospíšilová Š, Bryja V. Dave Z, et al. Among authors: krejci p. Front Cell Dev Biol. 2022 Feb 28;10:838871. doi: 10.3389/fcell.2022.838871. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35295854 Free PMC article.

6

Combination of electronically driven micromanipulation with laser desorption ionization mass spectrometry - The unique tool for analysis of seed coat layers and revealing the mystery of seed dormancy.

Krejčí P, Cechová MZ, Nádvorníková J, Barták P, Kobrlová L, Balarynová J, Smýkal P, Bednář P. Krejčí P, et al. Talanta. 2022 May 15;242:123303. doi: 10.1016/j.talanta.2022.123303. Epub 2022 Feb 10. Talanta. 2022. PMID: 35183978

7

4-PBA Treatment Improves Bone Phenotypes in the Aga2 Mouse Model of Osteogenesis Imperfecta.

Duran I, Zieba J, Csukasi F, Martin JH, Wachtell D, Barad M, Dawson B, Fafilek B, Jacobsen CM, Ambrose CG, Cohn DH, Krejci P, Lee BH, Krakow D. Duran I, et al. Among authors: krejci p. J Bone Miner Res. 2022 Apr;37(4):675-686. doi: 10.1002/jbmr.4501. Epub 2022 Jan 28. J Bone Miner Res. 2022. PMID: 34997935

8

Expanding horizons of achondroplasia treatment: current options and future developments.

Fafilek B, Bosakova M, Krejci P. Fafilek B, et al. Among authors: krejci p. Osteoarthritis Cartilage. 2022 Apr;30(4):535-544. doi: 10.1016/j.joca.2021.11.017. Epub 2021 Dec 2. Osteoarthritis Cartilage. 2022. PMID: 34864168 Review.

9

Cilia kinases in skeletal development and homeostasis.

Abraham SP, Nita A, Krejci P, Bosakova M. Abraham SP, et al. Among authors: krejci p. Dev Dyn. 2022 Apr;251(4):577-608. doi: 10.1002/dvdy.426. Epub 2021 Oct 18. Dev Dyn. 2022. PMID: 34582081 Review.

10

Loss of Sprouty Produces a Ciliopathic Skeletal Phenotype in Mice Through Upregulation of Hedgehog Signaling.

Hruba E, Kavkova M, Dalecka L, Macholan M, Zikmund T, Varecha M, Bosakova M, Kaiser J, Krejci P, Hovorakova M, Buchtova M. Hruba E, et al. Among authors: krejci p. J Bone Miner Res. 2021 Nov;36(11):2258-2274. doi: 10.1002/jbmr.4427. Epub 2021 Sep 20. J Bone Miner Res. 2021. PMID: 34423857

11

Oncogenic FGFR Fusions Produce Centrosome and Cilia Defects by Ectopic Signaling.

Nita A, Abraham SP, Krejci P, Bosakova M. Nita A, et al. Among authors: krejci p. Cells. 2021 Jun 9;10(6):1445. doi: 10.3390/cells10061445. Cells. 2021. PMID: 34207779 Free PMC article. Review.

12

An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice.

Kimura T, Bosakova M, Nonaka Y, Hruba E, Yasuda K, Futakawa S, Kubota T, Fafilek B, Gregor T, Abraham SP, Gomolkova R, Belaskova S, Pesl M, Csukasi F, Duran I, Fujiwara M, Kavkova M, Zikmund T, Kaiser J, Buchtova M, Krakow D, Nakamura Y, Ozono K, Krejci P. Kimura T, et al. Among authors: krejci p. Sci Transl Med. 2021 May 5;13(592):eaba4226. doi: 10.1126/scitranslmed.aba4226. Sci Transl Med. 2021. PMID: 33952673

13

Tooth agenesis: What do we know and is there a connection to cancer?

Bonczek O, Krejci P, Izakovicova-Holla L, Cernochova P, Kiss I, Vojtesek B. Bonczek O, et al. Among authors: krejci p. Clin Genet. 2021 Apr;99(4):493-502. doi: 10.1111/cge.13892. Epub 2021 Feb 16. Clin Genet. 2021. PMID: 33249565 Review.

14

Biallelic mutations in LAMA5 disrupts a skeletal noncanonical focal adhesion pathway and produces a distinct bent bone dysplasia.

Barad M, Csukasi F, Bosakova M, Martin JH, Zhang W, Paige Taylor S, Lachman RS, Zieba J, Bamshad M, Nickerson D, Chong JX, Cohn DH, Krejci P, Krakow D, Duran I. Barad M, et al. Among authors: krejci p. EBioMedicine. 2020 Dec;62:103075. doi: 10.1016/j.ebiom.2020.103075. Epub 2020 Nov 23. EBioMedicine. 2020. PMID: 33242826 Free PMC article.

15

Mutations in GRK2 cause Jeune syndrome by impairing Hedgehog and canonical Wnt signaling.

Bosakova M, Abraham SP, Nita A, Hruba E, Buchtova M, Taylor SP, Duran I, Martin J, Svozilova K, Barta T, Varecha M, Balek L, Kohoutek J, Radaszkiewicz T, Pusapati GV, Bryja V, Rush ET, Thiffault I, Nickerson DA, Bamshad MJ; University of Washington Center for Mendelian Genomics, Rohatgi R, Cohn DH, Krakow D, Krejci P. Bosakova M, et al. Among authors: krejci p. EMBO Mol Med. 2020 Nov 6;12(11):e11739. doi: 10.15252/emmm.201911739. Epub 2020 Oct 14. EMBO Mol Med. 2020. PMID: 33200460 Free PMC article.

16

SARS-CoV-2 Seroprevalence among a Southern U.S. Population Indicates Limited Asymptomatic Spread under Physical Distancing Measures.

Barzin A, Schmitz JL, Rosin S, Sirpal R, Almond M, Robinette C, Wells S, Hudgens M, Olshan A, Deen S, Krejci P, Quackenbush E, Chronowski K, Cornaby C, Goins J, Butler L, Aucoin J, Boyer K, Faulk J, Alston-Johnson D, Page C, Zhou Y, Fiscus L, Damania B, Dittmer DP, Peden DB. Barzin A, et al. Among authors: krejci p. mBio. 2020 Sep 29;11(5):e02426-20. doi: 10.1128/mBio.02426-20. mBio. 2020. PMID: 32994333 Free PMC article.

17

On proportional deformation paths in hypoplasticity.

Bauer E, Kovtunenko VA, Krejčí P, Krenn N, Siváková L, Zubkova AV. Bauer E, et al. Among authors: krejci p. Acta Mech. 2020;231(4):1603-1619. doi: 10.1007/s00707-019-02597-3. Epub 2020 Jan 28. Acta Mech. 2020. PMID: 32226061 Free PMC article.

18

Fluorinated derivatives of 2-phenyl-3-hydroxy-4(1H)-quinolinone as tubulin polymerization inhibitors.

Řehulka J, Vychodilová K, Krejčí P, Gurská S, Hradil P, Hajdúch M, Džubák P, Hlaváč J. Řehulka J, et al. Among authors: krejci p. Eur J Med Chem. 2020 Apr 15;192:112176. doi: 10.1016/j.ejmech.2020.112176. Epub 2020 Feb 21. Eur J Med Chem. 2020. PMID: 32120327

19

Elucidation of protein interactions necessary for the maintenance of the BCR-ABL signaling complex.

Gregor T, Bosakova MK, Nita A, Abraham SP, Fafilek B, Cernohorsky NH, Rynes J, Foldynova-Trantirkova S, Zackova D, Mayer J, Trantirek L, Krejci P. Gregor T, et al. Among authors: krejci p. Cell Mol Life Sci. 2020 Oct;77(19):3885-3903. doi: 10.1007/s00018-019-03397-7. Epub 2019 Dec 9. Cell Mol Life Sci. 2020. PMID: 31820037

20

Phosphoinositide 5-phosphatases SKIP and SHIP2 in ruffles, the endoplasmic reticulum and the nucleus: An update.

Ramos AR, Ghosh S, Suhel T, Chevalier C, Obeng EO, Fafilek B, Krejci P, Beck B, Erneux C. Ramos AR, et al. Among authors: krejci p. Adv Biol Regul. 2020 Jan;75:100660. doi: 10.1016/j.jbior.2019.100660. Epub 2019 Oct 7. Adv Biol Regul. 2020. PMID: 31628071

21

C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia.

Krejci P. Krejci P. N Engl J Med. 2019 Sep 26;381(13):1291. doi: 10.1056/NEJMc1910394. N Engl J Med. 2019. PMID: 31553847 No abstract available.

22

Fibroblast growth factor receptor influences primary cilium length through an interaction with intestinal cell kinase.

Kunova Bosakova M, Nita A, Gregor T, Varecha M, Gudernova I, Fafilek B, Barta T, Basheer N, Abraham SP, Balek L, Tomanova M, Fialova Kucerova J, Bosak J, Potesil D, Zieba J, Song J, Konik P, Park S, Duran I, Zdrahal Z, Smajs D, Jansen G, Fu Z, Ko HW, Hampl A, Trantirek L, Krakow D, Krejci P. Kunova Bosakova M, et al. Among authors: krejci p. Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4316-4325. doi: 10.1073/pnas.1800338116. Epub 2019 Feb 19. Proc Natl Acad Sci U S A. 2019. PMID: 30782830 Free PMC article.

23

The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling.

Csukasi F, Duran I, Barad M, Barta T, Gudernova I, Trantirek L, Martin JH, Kuo CY, Woods J, Lee H, Cohn DH, Krejci P, Krakow D. Csukasi F, et al. Among authors: krejci p. Sci Transl Med. 2018 Sep 19;10(459):eaat9356. doi: 10.1126/scitranslmed.aat9356. Sci Transl Med. 2018. PMID: 30232230 Free PMC article.

24

The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinases.

Fafilek B, Balek L, Bosakova MK, Varecha M, Nita A, Gregor T, Gudernova I, Krenova J, Ghosh S, Piskacek M, Jonatova L, Cernohorsky NH, Zieba JT, Kostas M, Haugsten EM, Wesche J, Erneux C, Trantirek L, Krakow D, Krejci P. Fafilek B, et al. Among authors: krejci p. Sci Signal. 2018 Sep 18;11(548):eaap8608. doi: 10.1126/scisignal.aap8608. Sci Signal. 2018. PMID: 30228226

25

Next generation sequencing reveals a novel nonsense mutation in MSX1 gene related to oligodontia.

Bonczek O, Bielik P, Krejčí P, Zeman T, Izakovičová-Hollá L, Šoukalová J, Vaněk J, Gerguri T, Balcar VJ, Šerý O. Bonczek O, et al. Among authors: krejci p. PLoS One. 2018 Sep 7;13(9):e0202989. doi: 10.1371/journal.pone.0202989. eCollection 2018. PLoS One. 2018. PMID: 30192788 Free PMC article.

26

Colicin F_Y inhibits pathogenic Yersinia enterocolitica in mice.

Bosák J, Micenková L, Hrala M, Pomorská K, Kunova Bosakova M, Krejci P, Göpfert E, Faldyna M, Šmajs D. Bosák J, et al. Among authors: krejci p. Sci Rep. 2018 Aug 16;8(1):12242. doi: 10.1038/s41598-018-30729-7. Sci Rep. 2018. PMID: 30115964 Free PMC article.

27

Inhibition of SHIP2 activity inhibits cell migration and could prevent metastasis in breast cancer cells.

Ghosh S, Scozzaro S, Ramos AR, Delcambre S, Chevalier C, Krejci P, Erneux C. Ghosh S, et al. Among authors: krejci p. J Cell Sci. 2018 Aug 16;131(16):jcs216408. doi: 10.1242/jcs.216408. J Cell Sci. 2018. PMID: 30012834

28

Nanodiamonds as "artificial proteins": Regulation of a cell signalling system using low nanomolar solutions of inorganic nanocrystals.

Balek L, Buchtova M, Kunova Bosakova M, Varecha M, Foldynova-Trantirkova S, Gudernova I, Vesela I, Havlik J, Neburkova J, Turner S, Krzyscik MA, Zakrzewska M, Klimaschewski L, Claus P, Trantirek L, Cigler P, Krejci P. Balek L, et al. Among authors: krejci p. Biomaterials. 2018 Sep;176:106-121. doi: 10.1016/j.biomaterials.2018.05.030. Epub 2018 May 21. Biomaterials. 2018. PMID: 29879652 Free article.

29

Regulation of ciliary function by fibroblast growth factor signaling identifies FGFR3-related disorders achondroplasia and thanatophoric dysplasia as ciliopathies.

Kunova Bosakova M, Varecha M, Hampl M, Duran I, Nita A, Buchtova M, Dosedelova H, Machat R, Xie Y, Ni Z, Martin JH, Chen L, Jansen G, Krakow D, Krejci P. Kunova Bosakova M, et al. Among authors: krejci p. Hum Mol Genet. 2018 Mar 15;27(6):1093-1105. doi: 10.1093/hmg/ddy031. Hum Mol Genet. 2018. PMID: 29360984 Free PMC article.

30

Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480.

Gudernova I, Balek L, Varecha M, Kucerova JF, Kunova Bosakova M, Fafilek B, Palusova V, Uldrijan S, Trantirek L, Krejci P. Gudernova I, et al. Among authors: krejci p. Oncotarget. 2017 Nov 27;8(65):109319-109331. doi: 10.18632/oncotarget.22674. eCollection 2017 Dec 12. Oncotarget. 2017. PMID: 29312610 Free PMC article.

31

Computer-assisted engineering of hyperstable fibroblast growth factor 2.

Dvorak P, Bednar D, Vanacek P, Balek L, Eiselleova L, Stepankova V, Sebestova E, Kunova Bosakova M, Konecna Z, Mazurenko S, Kunka A, Vanova T, Zoufalova K, Chaloupkova R, Brezovsky J, Krejci P, Prokop Z, Dvorak P, Damborsky J. Dvorak P, et al. Among authors: krejci p. Biotechnol Bioeng. 2018 Apr;115(4):850-862. doi: 10.1002/bit.26531. Epub 2018 Jan 24. Biotechnol Bioeng. 2018. PMID: 29278409

32

Proteomic analyses of signalling complexes associated with receptor tyrosine kinase identify novel members of fibroblast growth factor receptor 3 interactome.

Balek L, Nemec P, Konik P, Kunova Bosakova M, Varecha M, Gudernova I, Medalova J, Krakow D, Krejci P. Balek L, et al. Among authors: krejci p. Cell Signal. 2018 Jan;42:144-154. doi: 10.1016/j.cellsig.2017.10.003. Epub 2017 Oct 13. Cell Signal. 2018. PMID: 29030113

33

ARQ 087 inhibits FGFR signaling and rescues aberrant cell proliferation and differentiation in experimental models of craniosynostoses and chondrodysplasias caused by activating mutations in FGFR1, FGFR2 and FGFR3.

Balek L, Gudernova I, Vesela I, Hampl M, Oralova V, Kunova Bosakova M, Varecha M, Nemec P, Hall T, Abbadessa G, Hatch N, Buchtova M, Krejci P. Balek L, et al. Among authors: krejci p. Bone. 2017 Dec;105:57-66. doi: 10.1016/j.bone.2017.08.016. Epub 2017 Aug 18. Bone. 2017. PMID: 28826843

34

Tyrosine Kinase Expressed in Hepatocellular Carcinoma, TEC, Controls Pluripotency and Early Cell Fate Decisions of Human Pluripotent Stem Cells via Regulation of Fibroblast Growth Factor-2 Secretion.

Vanova T, Konecna Z, Zbonakova Z, La Venuta G, Zoufalova K, Jelinkova S, Varecha M, Rotrekl V, Krejci P, Nickel W, Dvorak P, Kunova Bosakova M. Vanova T, et al. Among authors: krejci p. Stem Cells. 2017 Sep;35(9):2050-2059. doi: 10.1002/stem.2660. Epub 2017 Jul 6. Stem Cells. 2017. PMID: 28631381 Free article.

35

Role of Primary Cilia in Odontogenesis.

Hampl M, Cela P, Szabo-Rogers HL, Kunova Bosakova M, Dosedelova H, Krejci P, Buchtova M. Hampl M, et al. Among authors: krejci p. J Dent Res. 2017 Aug;96(9):965-974. doi: 10.1177/0022034517713688. Epub 2017 Jun 12. J Dent Res. 2017. PMID: 28605602 Free PMC article. Review.

36

Statins do not inhibit the FGFR signaling in chondrocytes.

Fafilek B, Hampl M, Ricankova N, Vesela I, Balek L, Kunova Bosakova M, Gudernova I, Varecha M, Buchtova M, Krejci P. Fafilek B, et al. Among authors: krejci p. Osteoarthritis Cartilage. 2017 Sep;25(9):1522-1530. doi: 10.1016/j.joca.2017.05.014. Epub 2017 Jun 3. Osteoarthritis Cartilage. 2017. PMID: 28583899 Free article.

37

A Novel Role for the BMP Antagonist Noggin in Sensitizing Cells to Non-canonical Wnt-5a/Ror2/Disheveled Pathway Activation.

Bernatik O, Radaszkiewicz T, Behal M, Dave Z, Witte F, Mahl A, Cernohorsky NH, Krejci P, Stricker S, Bryja V. Bernatik O, et al. Among authors: krejci p. Front Cell Dev Biol. 2017 May 4;5:47. doi: 10.3389/fcell.2017.00047. eCollection 2017. Front Cell Dev Biol. 2017. PMID: 28523267 Free PMC article.

38

One reporter for in-cell activity profiling of majority of protein kinase oncogenes.

Gudernova I, Foldynova-Trantirkova S, Ghannamova BE, Fafilek B, Varecha M, Balek L, Hruba E, Jonatova L, Jelinkova I, Kunova Bosakova M, Trantirek L, Mayer J, Krejci P. Gudernova I, et al. Among authors: krejci p. Elife. 2017 Feb 15;6:e21536. doi: 10.7554/eLife.21536. Elife. 2017. PMID: 28199182 Free PMC article.

39

A Chaperone Complex Formed by HSP47, FKBP65, and BiP Modulates Telopeptide Lysyl Hydroxylation of Type I Procollagen.

Duran I, Martin JH, Weis MA, Krejci P, Konik P, Li B, Alanay Y, Lietman C, Lee B, Eyre D, Cohn DH, Krakow D. Duran I, et al. Among authors: krejci p. J Bone Miner Res. 2017 Jun;32(6):1309-1319. doi: 10.1002/jbmr.3095. Epub 2017 Apr 6. J Bone Miner Res. 2017. PMID: 28177155 Free PMC article.

40

[Multiple Endocrine Neoplasia I (Wermers Syndrome), Forms of Clinical Manifestation, 5 Case Studies].

Drbalová K, Herdová K, Krejčí P, Nývltová M, Solař S, Vedralová L, Záruba P, Netuka D, Bavor P. Drbalová K, et al. Among authors: krejci p. Vnitr Lek. 2016 Fall;62(9 Suppl 3):140-149. Vnitr Lek. 2016. PMID: 27734708 Czech.

41

MORN5 Expression during Craniofacial Development and Its Interaction with the BMP and TGFβ Pathways.

Cela P, Hampl M, Fu KK, Kunova Bosakova M, Krejci P, Richman JM, Buchtova M. Cela P, et al. Among authors: krejci p. Front Physiol. 2016 Aug 31;7:378. doi: 10.3389/fphys.2016.00378. eCollection 2016. Front Physiol. 2016. PMID: 27630576 Free PMC article.

42

Proximity Labeling Reveals Molecular Determinants of FGFR4 Endosomal Transport.

Haugsten EM, Sørensen V, Kunova Bosakova M, de Souza GA, Krejci P, Wiedlocha A, Wesche J. Haugsten EM, et al. Among authors: krejci p. J Proteome Res. 2016 Oct 7;15(10):3841-3855. doi: 10.1021/acs.jproteome.6b00652. Epub 2016 Sep 26. J Proteome Res. 2016. PMID: 27615514

43

An inactivating mutation in intestinal cell kinase, ICK, impairs hedgehog signalling and causes short rib-polydactyly syndrome.

Paige Taylor S, Kunova Bosakova M, Varecha M, Balek L, Barta T, Trantirek L, Jelinkova I, Duran I, Vesela I, Forlenza KN, Martin JH, Hampl A; University of Washington Center for Mendelian Genomics, Bamshad M, Nickerson D, Jaworski ML, Song J, Ko HW, Cohn DH, Krakow D, Krejci P. Paige Taylor S, et al. Among authors: krejci p. Hum Mol Genet. 2016 Sep 15;25(18):3998-4011. doi: 10.1093/hmg/ddw240. Epub 2016 Jul 27. Hum Mol Genet. 2016. PMID: 27466187 Free PMC article.

44

Noninvasive prenatal testing: more caution in counseling is needed in high risk pregnancies with ultrasound abnormalities.

Oneda B, Steindl K, Masood R, Reshetnikova I, Krejci P, Baldinger R, Reissmann R, Taralczak M, Guetg A, Wisser J, Fauchère JC, Rauch A. Oneda B, et al. Among authors: krejci p. Eur J Obstet Gynecol Reprod Biol. 2016 May;200:72-5. doi: 10.1016/j.ejogrb.2016.02.042. Epub 2016 Mar 8. Eur J Obstet Gynecol Reprod Biol. 2016. PMID: 26989803

45

Novel PAX9 gene polymorphisms and mutations and susceptibility to tooth agenesis in the Czech population.

Hlousková A, Bonczek O, Izakovicová-Hollá L, Lochman J, Soukalová J, Stembírek J, Mísek I, Cernochová P, Krejcí P, Vanek J, Šerý O. Hlousková A, et al. Among authors: krejci p. Neuro Endocrinol Lett. 2015;36(5):452-7. Neuro Endocrinol Lett. 2015. PMID: 26707046

46

Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes.

Gudernova I, Vesela I, Balek L, Buchtova M, Dosedelova H, Kunova M, Pivnicka J, Jelinkova I, Roubalova L, Kozubik A, Krejci P. Gudernova I, et al. Among authors: krejci p. Hum Mol Genet. 2016 Jan 1;25(1):9-23. doi: 10.1093/hmg/ddv441. Epub 2015 Oct 22. Hum Mol Genet. 2016. PMID: 26494904

47

Putting the brakes on chondrosarcoma.

Krejci P. Krejci P. Oncotarget. 2015 Sep 22;6(28):24598. doi: 10.18632/oncotarget.5242. Oncotarget. 2015. PMID: 26309085 Free PMC article. No abstract available.

48

Fate of the molar dental lamina in the monophyodont mouse.

Dosedělová H, Dumková J, Lesot H, Glocová K, Kunová M, Tucker AS, Veselá I, Krejčí P, Tichý F, Hampl A, Buchtová M. Dosedělová H, et al. Among authors: krejci p. PLoS One. 2015 May 26;10(5):e0127543. doi: 10.1371/journal.pone.0127543. eCollection 2015. PLoS One. 2015. PMID: 26010446 Free PMC article.

49

Instability restricts signaling of multiple fibroblast growth factors.

Buchtova M, Chaloupkova R, Zakrzewska M, Vesela I, Cela P, Barathova J, Gudernova I, Zajickova R, Trantirek L, Martin J, Kostas M, Otlewski J, Damborsky J, Kozubik A, Wiedlocha A, Krejci P. Buchtova M, et al. Among authors: krejci p. Cell Mol Life Sci. 2015 Jun;72(12):2445-59. doi: 10.1007/s00018-015-1856-8. Epub 2015 Feb 18. Cell Mol Life Sci. 2015. PMID: 25854632

50

A novel variant of FGFR3 causes proportionate short stature.

Kant SG, Cervenkova I, Balek L, Trantirek L, Santen GW, de Vries MC, van Duyvenvoorde HA, van der Wielen MJ, Verkerk AJ, Uitterlinden AG, Hannema SE, Wit JM, Oostdijk W, Krejci P, Losekoot M. Kant SG, et al. Among authors: krejci p. Eur J Endocrinol. 2015 Jun;172(6):763-70. doi: 10.1530/EJE-14-0945. Epub 2015 Mar 16. Eur J Endocrinol. 2015. PMID: 25777271

51

A screen of a large Czech cohort of oligodontia patients implicates a novel mutation in the PAX9 gene.

Šerý O, Bonczek O, Hloušková A, Černochová P, Vaněk J, Míšek I, Krejčí P, Izakovičová Hollá L. Šerý O, et al. Among authors: krejci p. Eur J Oral Sci. 2015 Apr;123(2):65-71. doi: 10.1111/eos.12170. Epub 2015 Feb 14. Eur J Oral Sci. 2015. PMID: 25683653

52

Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.

Wendt DJ, Dvorak-Ewell M, Bullens S, Lorget F, Bell SM, Peng J, Castillo S, Aoyagi-Scharber M, O'Neill CA, Krejci P, Wilcox WR, Rimoin DL, Bunting S. Wendt DJ, et al. Among authors: krejci p. J Pharmacol Exp Ther. 2015 Apr;353(1):132-49. doi: 10.1124/jpet.114.218560. Epub 2015 Feb 3. J Pharmacol Exp Ther. 2015. PMID: 25650377

53

Fibroblast growth factor and canonical WNT/β-catenin signaling cooperate in suppression of chondrocyte differentiation in experimental models of FGFR signaling in cartilage.

Buchtova M, Oralova V, Aklian A, Masek J, Vesela I, Ouyang Z, Obadalova T, Konecna Z, Spoustova T, Pospisilova T, Matula P, Varecha M, Balek L, Gudernova I, Jelinkova I, Duran I, Cervenkova I, Murakami S, Kozubik A, Dvorak P, Bryja V, Krejci P. Buchtova M, et al. Among authors: krejci p. Biochim Biophys Acta. 2015 May;1852(5):839-50. doi: 10.1016/j.bbadis.2014.12.020. Epub 2015 Jan 2. Biochim Biophys Acta. 2015. PMID: 25558817 Free article.

54

HSP47 and FKBP65 cooperate in the synthesis of type I procollagen.

Duran I, Nevarez L, Sarukhanov A, Wu S, Lee K, Krejci P, Weis M, Eyre D, Krakow D, Cohn DH. Duran I, et al. Among authors: krejci p. Hum Mol Genet. 2015 Apr 1;24(7):1918-28. doi: 10.1093/hmg/ddu608. Epub 2014 Dec 15. Hum Mol Genet. 2015. PMID: 25510505 Free PMC article.

55

Analytical solution for a class of network dynamics with mechanical and financial applications.

Krejčí P, Lamba H, Melnik S, Rachinskii D. Krejčí P, et al. Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Sep;90(3):032822. doi: 10.1103/PhysRevE.90.032822. Epub 2014 Sep 29. Phys Rev E Stat Nonlin Soft Matter Phys. 2014. PMID: 25314496

56

Effect of FGFR inhibitors on chicken limb development.

Horakova D, Cela P, Krejci P, Balek L, Moravcova Balkova S, Matalova E, Buchtova M. Horakova D, et al. Among authors: krejci p. Dev Growth Differ. 2014 Oct;56(8):555-72. doi: 10.1111/dgd.12156. Epub 2014 Oct 3. Dev Growth Differ. 2014. PMID: 25280231

57

High-resolution chromosomal microarrays in prenatal diagnosis significantly increase diagnostic power.

Oneda B, Baldinger R, Reissmann R, Reshetnikova I, Krejci P, Masood R, Ochsenbein-Kölble N, Bartholdi D, Steindl K, Morotti D, Faranda M, Baumer A, Asadollahi R, Joset P, Niedrist D, Breymann C, Hebisch G, Hüsler M, Mueller R, Prentl E, Wisser J, Zimmermann R, Rauch A. Oneda B, et al. Among authors: krejci p. Prenat Diagn. 2014 Jun;34(6):525-33. doi: 10.1002/pd.4342. Epub 2014 Mar 21. Prenat Diagn. 2014. PMID: 24919595

58

Fibroblast growth factor receptor 3 interacts with and activates TGFβ-activated kinase 1 tyrosine phosphorylation and NFκB signaling in multiple myeloma and bladder cancer.

Salazar L, Kashiwada T, Krejci P, Meyer AN, Casale M, Hallowell M, Wilcox WR, Donoghue DJ, Thompson LM. Salazar L, et al. Among authors: krejci p. PLoS One. 2014 Jan 23;9(1):e86470. doi: 10.1371/journal.pone.0086470. eCollection 2014. PLoS One. 2014. PMID: 24466111 Free PMC article.

59

The paradox of FGFR3 signaling in skeletal dysplasia: why chondrocytes growth arrest while other cells over proliferate.

Krejci P. Krejci P. Mutat Res Rev Mutat Res. 2014 Jan-Mar;759:40-8. doi: 10.1016/j.mrrev.2013.11.001. Epub 2013 Dec 1. Mutat Res Rev Mutat Res. 2014. PMID: 24295726 Review.

60

Expression of FGF19 in human embryonic stem cells.

Krejci P, Kunova M, Kubikova I, Trantirek L, Kozubik A, Dvorak P. Krejci P, et al. Stem Cells. 2013 Nov;31(11):2582-4. doi: 10.1002/stem.1493. Stem Cells. 2013. PMID: 23934687 Free article. No abstract available.

61

Phenotype-genotype correlations in patients with Marinesco-Sjögren syndrome.

Ezgu F, Krejci P, Li S, de Sousa C, Graham JM Jr, Hansmann I, He W, Porpora K, Wand D, Wertelecki W, Schneider A, Wilcox WR. Ezgu F, et al. Among authors: krejci p. Clin Genet. 2014 Jul;86(1):74-84. doi: 10.1111/cge.12230. Epub 2013 Jul 30. Clin Genet. 2014. PMID: 23829326

62

Mild clinical presentation and prolonged survival of a patient with fumarase deficiency due to the combination of a known and a novel mutation in FH gene.

Ezgu F, Krejci P, Wilcox WR. Ezgu F, et al. Among authors: krejci p. Gene. 2013 Jul 25;524(2):403-6. doi: 10.1016/j.gene.2013.03.026. Epub 2013 Apr 20. Gene. 2013. PMID: 23612258

63

The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of B-lymphocyte migration.

Kaucká M, Plevová K, Pavlová S, Janovská P, Mishra A, Verner J, Procházková J, Krejcí P, Kotasková J, Ovesná P, Tichy B, Brychtová Y, Doubek M, Kozubík A, Mayer J, Pospísilová S, Bryja V. Kaucká M, et al. Among authors: krejci p. Cancer Res. 2013 Mar 1;73(5):1491-501. doi: 10.1158/0008-5472.CAN-12-1752. Epub 2013 Jan 21. Cancer Res. 2013. PMID: 23338609

64

Apoptosis inhibitor 5 (API-5; AAC-11; FIF) is upregulated in human carcinomas in vivo.

Koci L, Chlebova K, Hyzdalova M, Hofmanova J, Jira M, Kysela P, Kozubik A, Kala Z, Krejci P. Koci L, et al. Among authors: krejci p. Oncol Lett. 2012 Apr 1;3(4):913-916. doi: 10.3892/ol.2012.593. Epub 2012 Feb 3. Oncol Lett. 2012. PMID: 22741017 Free PMC article.

65

p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice.

Wang Y, Zhou X, Oberoi K, Phelps R, Couwenhoven R, Sun M, Rezza A, Holmes G, Percival CJ, Friedenthal J, Krejci P, Richtsmeier JT, Huso DL, Rendl M, Jabs EW. Wang Y, et al. Among authors: krejci p. J Clin Invest. 2012 Jun;122(6):2153-64. doi: 10.1172/JCI62644. Epub 2012 May 15. J Clin Invest. 2012. PMID: 22585574 Free PMC article.

66

Receptor tyrosine kinases activate canonical WNT/β-catenin signaling via MAP kinase/LRP6 pathway and direct β-catenin phosphorylation.

Krejci P, Aklian A, Kaucka M, Sevcikova E, Prochazkova J, Masek JK, Mikolka P, Pospisilova T, Spoustova T, Weis M, Paznekas WA, Wolf JH, Gutkind JS, Wilcox WR, Kozubik A, Jabs EW, Bryja V, Salazar L, Vesela I, Balek L. Krejci P, et al. PLoS One. 2012;7(4):e35826. doi: 10.1371/journal.pone.0035826. Epub 2012 Apr 27. PLoS One. 2012. PMID: 22558232 Free PMC article.

67

Exome sequencing identifies PDE4D mutations in acrodysostosis.

Lee H, Graham JM Jr, Rimoin DL, Lachman RS, Krejci P, Tompson SW, Nelson SF, Krakow D, Cohn DH. Lee H, et al. Among authors: krejci p. Am J Hum Genet. 2012 Apr 6;90(4):746-51. doi: 10.1016/j.ajhg.2012.03.004. Epub 2012 Mar 29. Am J Hum Genet. 2012. PMID: 22464252 Free PMC article.

68

Bent bone dysplasia-FGFR2 type, a distinct skeletal disorder, has deficient canonical FGF signaling.

Merrill AE, Sarukhanov A, Krejci P, Idoni B, Camacho N, Estrada KD, Lyons KM, Deixler H, Robinson H, Chitayat D, Curry CJ, Lachman RS, Wilcox WR, Krakow D. Merrill AE, et al. Among authors: krejci p. Am J Hum Genet. 2012 Mar 9;90(3):550-7. doi: 10.1016/j.ajhg.2012.02.005. Epub 2012 Mar 1. Am J Hum Genet. 2012. PMID: 22387015 Free PMC article.

69

Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.

Foldynova-Trantirkova S, Wilcox WR, Krejci P. Foldynova-Trantirkova S, et al. Among authors: krejci p. Hum Mutat. 2012 Jan;33(1):29-41. doi: 10.1002/humu.21636. Epub 2011 Nov 16. Hum Mutat. 2012. PMID: 22045636 Free PMC article. Review.

70

Post-translational modifications regulate signalling by Ror1.

Kaucká M, Krejčí P, Plevová K, Pavlová S, Procházková J, Janovská P, Valnohová J, Kozubík A, Pospíšilová S, Bryja V. Kaucká M, et al. Among authors: krejci p. Acta Physiol (Oxf). 2011 Nov;203(3):351-62. doi: 10.1111/j.1748-1716.2011.02306.x. Epub 2011 May 27. Acta Physiol (Oxf). 2011. PMID: 21481194

71

Sequential activation and inactivation of Dishevelled in the Wnt/beta-catenin pathway by casein kinases.

Bernatik O, Ganji RS, Dijksterhuis JP, Konik P, Cervenka I, Polonio T, Krejci P, Schulte G, Bryja V. Bernatik O, et al. Among authors: krejci p. J Biol Chem. 2011 Mar 25;286(12):10396-410. doi: 10.1074/jbc.M110.169870. Epub 2011 Feb 1. J Biol Chem. 2011. PMID: 21285348 Free PMC article.

72

The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival.

Scuto A, Krejci P, Popplewell L, Wu J, Wang Y, Kujawski M, Kowolik C, Xin H, Chen L, Wang Y, Kretzner L, Yu H, Wilcox WR, Yen Y, Forman S, Jove R. Scuto A, et al. Among authors: krejci p. Leukemia. 2011 Mar;25(3):538-50. doi: 10.1038/leu.2010.289. Epub 2010 Dec 17. Leukemia. 2011. PMID: 21164517 Free PMC article.

73

Mitogen-activated protein kinases promote WNT/beta-catenin signaling via phosphorylation of LRP6.

Červenka I, Wolf J, Mašek J, Krejci P, Wilcox WR, Kozubík A, Schulte G, Gutkind JS, Bryja V. Červenka I, et al. Among authors: krejci p. Mol Cell Biol. 2011 Jan;31(1):179-89. doi: 10.1128/MCB.00550-10. Epub 2010 Oct 25. Mol Cell Biol. 2011. PMID: 20974802 Free PMC article.

74

Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration.

Foldynová-Trantírková S, Sekyrová P, Tmejová K, Brumovská E, Bernatík O, Blankenfeldt W, Krejcí P, Kozubík A, Dolezal T, Trantírek L, Bryja V. Foldynová-Trantírková S, et al. Among authors: krejci p. Breast Cancer Res. 2010;12(3):R30. doi: 10.1186/bcr2581. Epub 2010 May 27. Breast Cancer Res. 2010. PMID: 20507565 Free PMC article.

75

NF449 is a novel inhibitor of fibroblast growth factor receptor 3 (FGFR3) signaling active in chondrocytes and multiple myeloma cells.

Krejci P, Murakami S, Prochazkova J, Trantirek L, Chlebova K, Ouyang Z, Aklian A, Smutny J, Bryja V, Kozubik A, Wilcox WR. Krejci P, et al. J Biol Chem. 2010 Jul 2;285(27):20644-53. doi: 10.1074/jbc.M109.083626. Epub 2010 May 3. J Biol Chem. 2010. PMID: 20439987 Free PMC article.

76

FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence.

Krejci P, Prochazkova J, Smutny J, Chlebova K, Lin P, Aklian A, Bryja V, Kozubik A, Wilcox WR. Krejci P, et al. Bone. 2010 Jul;47(1):102-10. doi: 10.1016/j.bone.2010.03.021. Epub 2010 Mar 31. Bone. 2010. PMID: 20362703 Free PMC article.

77

Negative regulation of Wnt signaling mediated by CK1-phosphorylated Dishevelled via Ror2.

Witte F, Bernatik O, Kirchner K, Masek J, Mahl A, Krejci P, Mundlos S, Schambony A, Bryja V, Stricker S. Witte F, et al. Among authors: krejci p. FASEB J. 2010 Jul;24(7):2417-26. doi: 10.1096/fj.09-150615. Epub 2010 Mar 9. FASEB J. 2010. PMID: 20215527

78

Molecular pathology of the fibroblast growth factor family.

Krejci P, Prochazkova J, Bryja V, Kozubik A, Wilcox WR. Krejci P, et al. Hum Mutat. 2009 Sep;30(9):1245-55. doi: 10.1002/humu.21067. Hum Mutat. 2009. PMID: 19621416 Free PMC article. Review.

79

A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells.

Salazar L, Kashiwada T, Krejci P, Muchowski P, Donoghue D, Wilcox WR, Thompson LM. Salazar L, et al. Among authors: krejci p. Hum Mol Genet. 2009 Jun 1;18(11):1951-61. doi: 10.1093/hmg/ddp116. Epub 2009 Mar 13. Hum Mol Genet. 2009. PMID: 19286672 Free PMC article.

80

Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage.

Krejci P, Salazar L, Kashiwada TA, Chlebova K, Salasova A, Thompson LM, Bryja V, Kozubik A, Wilcox WR. Krejci P, et al. PLoS One. 2008;3(12):e3961. doi: 10.1371/journal.pone.0003961. Epub 2008 Dec 17. PLoS One. 2008. PMID: 19088846 Free PMC article.

81

Fibroblast growth factor inhibits interferon gamma-STAT1 and interleukin 6-STAT3 signaling in chondrocytes.

Krejci P, Prochazkova J, Bryja V, Jelinkova P, Pejchalova K, Kozubik A, Thompson LM, Wilcox WR. Krejci P, et al. Cell Signal. 2009 Jan;21(1):151-60. doi: 10.1016/j.cellsig.2008.10.006. Epub 2008 Oct 12. Cell Signal. 2009. PMID: 18950705 Free PMC article.

82

FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway.

Matsushita T, Wilcox WR, Chan YY, Kawanami A, Bükülmez H, Balmes G, Krejci P, Mekikian PB, Otani K, Yamaura I, Warman ML, Givol D, Murakami S. Matsushita T, et al. Among authors: krejci p. Hum Mol Genet. 2009 Jan 15;18(2):227-40. doi: 10.1093/hmg/ddn339. Epub 2008 Oct 15. Hum Mol Genet. 2009. PMID: 18923003 Free PMC article.

83

High molecular weight FGF2: the biology of a nuclear growth factor.

Chlebova K, Bryja V, Dvorak P, Kozubik A, Wilcox WR, Krejci P. Chlebova K, et al. Among authors: krejci p. Cell Mol Life Sci. 2009 Jan;66(2):225-35. doi: 10.1007/s00018-008-8440-4. Cell Mol Life Sci. 2009. PMID: 18850066 Free PMC article. Review.

84

STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes.

Krejci P, Salazar L, Goodridge HS, Kashiwada TA, Schibler MJ, Jelinkova P, Thompson LM, Wilcox WR. Krejci P, et al. J Cell Sci. 2008 Feb 1;121(Pt 3):272-81. doi: 10.1242/jcs.017160. Epub 2008 Jan 15. J Cell Sci. 2008. PMID: 18198189

85

The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia.

Krejci P, Pejchalova K, Rosenbloom BE, Rosenfelt FP, Tran EL, Laurell H, Wilcox WR. Krejci P, et al. J Leukoc Biol. 2007 Dec;82(6):1363-4. doi: 10.1189/jlb.0607425. Epub 2007 Sep 7. J Leukoc Biol. 2007. PMID: 17827341 No abstract available.

86

C-natriuretic peptide: an important regulator of cartilage.

Pejchalova K, Krejci P, Wilcox WR. Pejchalova K, et al. Among authors: krejci p. Mol Genet Metab. 2007 Nov;92(3):210-5. doi: 10.1016/j.ymgme.2007.06.014. Epub 2007 Aug 6. Mol Genet Metab. 2007. PMID: 17681481 Review.

87

Simple, mammalian cell-based assay for identification of inhibitors of the Erk MAP kinase pathway.

Krejci P, Pejchalova K, Wilcox WR. Krejci P, et al. Invest New Drugs. 2007 Aug;25(4):391-5. doi: 10.1007/s10637-007-9054-7. Epub 2007 Apr 26. Invest New Drugs. 2007. PMID: 17458503

88

Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligands expressed in human fetal growth plate cartilage.

Krejci P, Krakow D, Mekikian PB, Wilcox WR. Krejci P, et al. Pediatr Res. 2007 Mar;61(3):267-72. doi: 10.1203/pdr.0b013e318030d157. Pediatr Res. 2007. PMID: 17314681

89

Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins.

Krejci P, Masri B, Salazar L, Farrington-Rock C, Prats H, Thompson LM, Wilcox WR. Krejci P, et al. J Biol Chem. 2007 Feb 2;282(5):2929-36. doi: 10.1074/jbc.M606144200. Epub 2006 Dec 4. J Biol Chem. 2007. PMID: 17145761 Free article.

90

The fibroblast growth factors in multiple myeloma.

Krejci P, Mekikian PB, Wilcox WR. Krejci P, et al. Leukemia. 2006 Jun;20(6):1165-8. doi: 10.1038/sj.leu.2404202. Leukemia. 2006. PMID: 16598309 No abstract available.

91

Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis.

Krejci P, Masri B, Fontaine V, Mekikian PB, Weis M, Prats H, Wilcox WR. Krejci P, et al. J Cell Sci. 2005 Nov 1;118(Pt 21):5089-100. doi: 10.1242/jcs.02618. Epub 2005 Oct 18. J Cell Sci. 2005. PMID: 16234329

92

Mutations in the EVC1 gene are not a common finding in the Ellis-van Creveld and short rib-polydactyly type III syndromes.

Takamine Y, Krejci P, Mekikian PB, Wilcox WR. Takamine Y, et al. Among authors: krejci p. Am J Med Genet A. 2004 Sep 15;130A(1):96-7. doi: 10.1002/ajmg.a.20579. Am J Med Genet A. 2004. PMID: 15368503 No abstract available.

93

FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells.

Krejci P, Bryja V, Pachernik J, Hampl A, Pogue R, Mekikian P, Wilcox WR. Krejci P, et al. Exp Cell Res. 2004 Jul 1;297(1):152-64. doi: 10.1016/j.yexcr.2004.03.011. Exp Cell Res. 2004. PMID: 15194433

94

The role of p27(Kip1) in maintaining the levels of D-type cyclins in vivo.

Bryja V, Pacherník J, Faldíková L, Krejcí P, Pogue R, Nevrivá I, Dvorák P, Hampl A. Bryja V, et al. Among authors: krejci p. Biochim Biophys Acta. 2004 May 3;1691(2-3):105-16. doi: 10.1016/j.bbamcr.2004.01.001. Biochim Biophys Acta. 2004. PMID: 15110991 Free article.

95

FGF-2 expression and its action in human leukemia and lymphoma cell lines.

Krejci P, Faitova J, Laurell H, Hampl A, Dvorak P. Krejci P, et al. Leukemia. 2003 Apr;17(4):818-20. doi: 10.1038/sj.leu.2402861. Leukemia. 2003. PMID: 12682649 No abstract available.

96

Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells.

Preclíková H, Bryja V, Pacherník J, Krejcí P, Dvorák P, Hampl A. Preclíková H, et al. Among authors: krejci p. Cell Growth Differ. 2002 Sep;13(9):421-30. Cell Growth Differ. 2002. PMID: 12354751

97

Effects of central infusions of neuropeptide Y on the somatotropic axis in sheep fed on two levels of protein.

Gładysz A, Krejci P, Simůnek J, Polkowska J. Gładysz A, et al. Among authors: krejci p. Acta Neurobiol Exp (Wars). 2001;61(4):255-66. Acta Neurobiol Exp (Wars). 2001. PMID: 11905147 Free article.

98

Changes in the expression of FGFR3 in patients with chronic myeloid leukaemia receiving transplants of allogeneic peripheral blood stem cells.

Dvorakova D, Krejci P, Mayer J, Fajkus J, Hampl A, Dvorak P. Dvorakova D, et al. Among authors: krejci p. Br J Haematol. 2001 Jun;113(3):832-5. doi: 10.1046/j.1365-2141.2001.02829.x. Br J Haematol. 2001. PMID: 11380477

99

Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells.

Vondrácek J, Sheard MA, Krejcí P, Minksová K, Hofmanová J, Kozubík A. Vondrácek J, et al. Among authors: krejci p. J Leukoc Biol. 2001 May;69(5):794-802. J Leukoc Biol. 2001. PMID: 11358989

100

FGF-2 abnormalities in B cell chronic lymphocytic and chronic myeloid leukemias.

Krejcí P, Dvoráková D, Krahulcová E, Pacherník J, Mayer J, Hampl A, Dvorák P. Krejcí P, et al. Leukemia. 2001 Feb;15(2):228-37. doi: 10.1038/sj.leu.2402012. Leukemia. 2001. PMID: 11236938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results